Tag - Clesrovimab

GHP News Latest Science

Critical methodological summary of the SMART trial:
Clesrovimab vs. Palivizumab in high-risk infants

Reference: Zar HJ, Bont LJ, Manzoni P, et al. Clesrovimab in infants and children at increased risk for severe RSV disease. N Engl J Med. 2025;393(13):1343-1345. This interim analysis from the SMART trial represents a...

7 October, 2025

5 min read

GHP News Latest Science

How to best prevent RSV in infants?

Significant progress has been made in preventing respiratory syncytial virus (RSV) infections in infants, with the licensing of at least three prophylactic products. RSV-associated hospitalization rates reach...

7 October, 2025

6 min read

Tag - Clesrovimab

Critical methodological summary of the SMART trial:Clesrovimab vs. Palivizumab in high-risk infants

How to best prevent RSV in infants?

Critical methodological summary of the SMART trial:
Clesrovimab vs. Palivizumab in high-risk infants